141 related articles for article (PubMed ID: 30430942)
1. Depression Assessment in Clinical Trials and Pre-clinical Tests: A Critical Review.
Ferreira MF; Castanheira L; Sebastião AM; Telles-Correia D
Curr Top Med Chem; 2018; 18(19):1677-1703. PubMed ID: 30430942
[TBL] [Abstract][Full Text] [Related]
2. Anxiety Assessment in Pre-clinical Tests and in Clinical Trials: A Critical Review.
Castanheira L; Ferreira MF; Sebastião AM; Telles-Correia D
Curr Top Med Chem; 2018; 18(19):1656-1676. PubMed ID: 30430939
[TBL] [Abstract][Full Text] [Related]
3. Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice.
Castagné V; Moser P; Roux S; Porsolt RD
Curr Protoc Pharmacol; 2010 Jun; Chapter 5():Unit 5.8. PubMed ID: 22294373
[TBL] [Abstract][Full Text] [Related]
4. Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice.
Castagné V; Moser P; Roux S; Porsolt RD
Curr Protoc Neurosci; 2011 Apr; Chapter 8():Unit 8.10A. PubMed ID: 21462162
[TBL] [Abstract][Full Text] [Related]
5. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice.
Cryan JF; Mombereau C; Vassout A
Neurosci Biobehav Rev; 2005; 29(4-5):571-625. PubMed ID: 15890404
[TBL] [Abstract][Full Text] [Related]
6. The forced swim test has poor accuracy for identifying novel antidepressants.
Trunnell ER; Carvalho C
Drug Discov Today; 2021 Dec; 26(12):2898-2904. PubMed ID: 34390862
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant-like effects of rosiglitazone, a PPARγ agonist, in the rat forced swim and mouse tail suspension tests.
Eissa Ahmed AA; Al-Rasheed NM; Al-Rasheed NM
Behav Pharmacol; 2009 Oct; 20(7):635-42. PubMed ID: 19745723
[TBL] [Abstract][Full Text] [Related]
8. Potential antidepressant effect of amantadine: a review of preclinical studies and clinical trials.
Raupp-Barcaro IF; Vital MA; Galduróz JC; Andreatini R
Braz J Psychiatry; 2018; 40(4):449-458. PubMed ID: 29898194
[TBL] [Abstract][Full Text] [Related]
9. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action.
Andreasen JT; Fitzpatrick CM; Larsen M; Skovgaard L; Nielsen SD; Clausen RP; Troelsen K; Pickering DS
Brain Res; 2015 Mar; 1601():117-26. PubMed ID: 25578259
[TBL] [Abstract][Full Text] [Related]
10. A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests.
Bourin M; Chenu F; Ripoll N; David DJ
Behav Brain Res; 2005 Nov; 164(2):266-9. PubMed ID: 16087251
[TBL] [Abstract][Full Text] [Related]
11. Rodent models of depression: forced swimming and tail suspension behavioral despair tests in rats and mice.
Porsolt RD; Brossard G; Hautbois C; Roux S
Curr Protoc Neurosci; 2001 May; Chapter 8():Unit 8.10A. PubMed ID: 18428536
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
[TBL] [Abstract][Full Text] [Related]
13. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?
Zimmerman M; Mattia JI; Posternak MA
Am J Psychiatry; 2002 Mar; 159(3):469-73. PubMed ID: 11870014
[TBL] [Abstract][Full Text] [Related]
14. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
Leblé N; Radon L; Rabot M; Godart N
Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
[TBL] [Abstract][Full Text] [Related]
15. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
[TBL] [Abstract][Full Text] [Related]
16. Behavioral profile of Hypericum perforatum (St. John's Wort) extract. A comparison with standard antidepressants in animal models of depression.
Bukhari IA; Dar A
Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1082-9. PubMed ID: 23661522
[TBL] [Abstract][Full Text] [Related]
17. Experimental methods for evaluation of psychotropic agents in rodents: II-Antidepressants.
Bhattacharya SK; Satyan KS; Ramanathan M
Indian J Exp Biol; 1999 Feb; 37(2):117-23. PubMed ID: 10641129
[TBL] [Abstract][Full Text] [Related]
18. Identifying fast-onset antidepressants using rodent models.
Ramaker MJ; Dulawa SC
Mol Psychiatry; 2017 May; 22(5):656-665. PubMed ID: 28322276
[TBL] [Abstract][Full Text] [Related]
19. Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression.
Hughes ZA; Neal SJ; Smith DL; Sukoff Rizzo SJ; Pulicicchio CM; Lotarski S; Lu S; Dwyer JM; Brennan J; Olsen M; Bender CN; Kouranova E; Andree TH; Harrison JE; Whiteside GT; Springer D; O'Neil SV; Leonard SK; Schechter LE; Dunlop J; Rosenzweig-Lipson S; Ring RH
Neuropharmacology; 2013 Mar; 66():202-14. PubMed ID: 22551786
[TBL] [Abstract][Full Text] [Related]
20. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment.
Duman CH; Schlesinger L; Kodama M; Russell DS; Duman RS
Biol Psychiatry; 2007 Mar; 61(5):661-70. PubMed ID: 16945347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
